Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2020

Dec 31, 2020

32093_dirs_2020-12-30_dcc6f3db-8dfe-41e7-a7b7-d14abc6801aa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2020-12-29

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-29 Common Stock X 376065 $7.01 Acquired 11659781 Direct
2020-12-29 Common Stock X 8214 $7.01 Acquired 330019 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-29 Warrant (right to buy) $7.01 X 376065 Disposed 2025-06-15 Common Stock (376065) Direct
2020-12-29 Warrant (right to buy) $7.01 X 8214 Disposed 2025-06-15 Common Stock (8214) Indirect

Footnotes

F1: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.